Zirconium oxide nanoparticles applied in photocatalysis
BR102012021839A2
Antioxidant synthesis process, based on cashew castle bark (lcc) liquid, in the presence of electrolytic reaction triethylamine
BR102012021844A2
Obtaining pectin blendes with tartaric acid and plasifying additives
BR102012021833A2
Pharmaceutical products based on 2 - [(2,6-dichlorbenzylidene) amino] -5,6-diidro-4h-cyclopenta [b] thiophen-3-carbonitril) (5tio1) with ansiolytic, sedatic and hypnotic property
BR102012009539A2
Cosmetic formulation of fagifolia mart. et zucc (combretaceae)
BR102012004990A2
Nutritive bar production process taking as ingredients derived from cassava, honey, babaçu mesocarpo, peduncle and cashew
BRPI1106397A2
Phytol applications in pharmaceutical formulations with ansiolitic and antidepressive properties
BRPI1107225A2
Pharmaceutical formulations from the ethanolic extract of mikania glomerata sprengel leaves
BRPI1106549A2
Pharmaceutical formulation from vitex agnus-castus
BRPI1104729A2
antioxidant synthesis process obtained from cashew nut shell liquid by electrolysis.
BRPI1102393A2
Pharmaceutical composition for treatment of ovarian dysfunctions and induction of follicular growth and ovulation in mammals and use
BRPI1105457A2
Pharmaceutical formulation of lippia essential oil origanoids h.b.k.
BRPI0904110A2
process of obtaining epiisopiloturin and its application in the fight against parasitic infections
BRPI0903451A2
process for obtaining benznidazole inclusion complexes with cyclodextrin derivatives
